Navigation Links
Study of Cannabinoid Medicine for Pain Found Patients Got 'High,' but Effects Not Related to Pain Relief
Date:1/28/2009

HONOLULU, Jan. 28 /PRNewswire/ -- Researchers at Brigham and Women's Hospital found that patients taking cannabinoid medicines for pain may be getting "high," but these effects were unrelated to relief from their pain symptoms. Results of their study, one of the first to examine the addictive potential of this class of pain medicine, were presented today at the American Academy of Pain Medicine's 25th Annual Meeting.

In the study, Ajay Wasan, MD MSc and colleagues found that when used for non-cancer pain management, the cannabinoid class of medicines (such as dronabinol), got patients "high," but the majority of subjects experienced significant pain relief independent of these psychoactive effects. Results indicate that these medicines have the likelihood of an addiction similar to smoking marijuana, leading researchers to conclude the abuse potential of this class should be studied further.

Using the Addiction Research Center Inventory (ARCI), the gold-standard for determining the abuse liability of substances, Dr. Wasan and colleagues at McLean Hospital looked at two different patient populations to compare the effects of medicinal, synthetic cannabinoid and marijuana. The first population was suffering from pain, and took each of the following at separate visits where they were observed for eight hours: placebo, 10mg, or 20 mg of dronabinol. The second population was not suffering from pain, but they were monitored every 30 minutes after smoking a high and low strength marijuana cigarette. Participants in both populations were given the ARCI every hour. After two hours, patients in the first population (synthetic cannabinoid medicine) were found to have the same psychoactive effects that patients from the second population (smoked marijuana) did after 30 minutes.

"Based on our study we believe the addictive qualities of this class of medicines need more investigation. In our study, patients taking the medicine, like the patients smoking the marijuana, were, essentially, stoned. However, they didn't report less pain, indicating the pain relief properties were independent of the psychoactive effects," said Dr. Wasan, lead author of the study, and director of clinical pain research at Brigham and Women's Hospital. "We discovered that both the synthetic cannabinoid medicines we studied and marijuana have similar psychoactive properties and suggestive of an addiction potential."

    Poster Session Information (Poster 193)
    Begins: 3:30 PM (Hawaiian Time), Wednesday, January 28, 2009
    Ends:  10:00 AM (Hawaiian Time), Thursday, January 29, 2009
    Location:  Coral Ballroom Foyer, Hilton Hawaiian Village

About the AAPM

For more than 25 years, the American Academy of Pain Medicine (AAPM) has been the medical specialty society representing more than 2,200 physicians practicing in the field of pain medicine. The Academy is involved in education, training, advocacy and research in the specialty of pain medicine. Information is available on the practice of pain medicine at http://www.painmed.org.


'/>"/>
SOURCE American Academy of Pain Medicine
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Shows No Standardized Approach to Epidural Steroid Injections for Back Pain
2. ISTA Pharmaceuticals Announces Positive Results for Phase IIb Study of Ecabet Sodium
3. Intercell AG Partners with Inclinix to Enroll 1800 Volunteers for Phase III Travelers Diarrhea Vaccine Study
4. Thomson Reuters Study Finds Sharp Increase in Use of Sleep Medications by Young Adults
5. Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP
6. Study Shows How Defective DNA Repair Triggers Two Neurological Diseases
7. New Overall Survival Study Results Confirm Oral Xeloda(R) plus Oxaliplatin (XELOX) is Comparable to FOLFOX-4 for the First-Line Treatment of Advanced Colorectal Cancer
8. New Study First to Confirm Sandostatin LAR(R) Depot Controls Tumor Growth in Patients With Rare Gastrointestinal Tumors
9. VA-NIH Study Offers Hope for Parkinsons Patients
10. Uroplasty Highlights Results From Clinical Study on Macroplastique(R) for the Treatment of Stress Urinary Incontinence
11. Reproductive Partners Participates in New IVF Progesterone Delivery System Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
(Date:6/24/2016)... 24, 2016  Collagen Matrix, Inc., ("Collagen Matrix") ... manufacturing of collagen and mineral based medical devices ... Bill Messer has joined the company ... leverage the growing portfolio of oral surgery, neurosurgery, ... Bill joins the Collagen Matrix executive team as ...
(Date:6/24/2016)... Dublin ... of the " Global Markets for Spectroscopy Equipment" ... This report focuses on the global ... including its applications in various applications. The report deals ... three main industries: pharmaceutical and biotechnology, food and beverage, ...
Breaking Medicine Technology:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... for mental health professionals, announced today its affiliation with Tennessee Counseling Association. ... solutions to the network of the Tennessee Counseling Association, adding exclusive benefits and ...
(Date:6/26/2016)... , ... June 26, 2016 , ... On June 10-11, ... of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, ... the city’s history as home to some of the world’s leading providers of cereal ...
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic ... many turn to unhealthy avenues, such as drug or alcohol abuse, as a coping ... released tools for healthy coping following a traumatic event. , Trauma sufferers tend to ...
Breaking Medicine News(10 mins):